237 related articles for article (PubMed ID: 15183926)
1. The blocking activity of birch pollen-specific immunotherapy-induced IgG4 is not qualitatively superior to that of other IgG subclasses.
Ejrnaes AM; Bodtger U; Larsen JN; Svenson M
Mol Immunol; 2004 Jul; 41(5):471-8. PubMed ID: 15183926
[TBL] [Abstract][Full Text] [Related]
2. Kinetics, cross-reactivity, and specificity of Bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollen.
Subbarayal B; Schiller D; Möbs C; de Jong NW; Ebner C; Reider N; Bartel D; Lidholm J; Pfützner W; Gerth van Wijk R; Vieths S; Bohle B
Allergy; 2013 Nov; 68(11):1377-86. PubMed ID: 24053565
[TBL] [Abstract][Full Text] [Related]
3. Is immunotherapy-induced birch-pollen-specific IgG4 a marker for decreased allergen-specific sensitivity?
Bodtger U; Ejrnaes AM; Hummelshoj L; Jacobi HH; Poulsen LK; Svenson M
Int Arch Allergy Immunol; 2005 Apr; 136(4):340-6. PubMed ID: 15741732
[TBL] [Abstract][Full Text] [Related]
4. Birch pollen immunotherapy results in long-term loss of Bet v 1-specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies.
Möbs C; Ipsen H; Mayer L; Slotosch C; Petersen A; Würtzen PA; Hertl M; Pfützner W
J Allergy Clin Immunol; 2012 Nov; 130(5):1108-1116.e6. PubMed ID: 23021882
[TBL] [Abstract][Full Text] [Related]
5.
Aglas L; Bethanis A; Chrusciel P; Stolz F; Gruen M; Jaakkola UM; Jongejan L; Yatkin E; Van Ree R
Front Immunol; 2020; 11():2118. PubMed ID: 33013894
[TBL] [Abstract][Full Text] [Related]
6. IgE-blocking antibodies following SLIT with recombinant Mal d 1 accord with improved apple allergy.
Sánchez Acosta G; Kinaciyan T; Kitzmüller C; Möbs C; Pfützner W; Bohle B
J Allergy Clin Immunol; 2020 Oct; 146(4):894-900.e2. PubMed ID: 32259540
[TBL] [Abstract][Full Text] [Related]
7. Effect of tree pollen specific, subcutaneous immunotherapy on the oral allergy syndrome to apple and hazelnut.
Bucher X; Pichler WJ; Dahinden CA; Helbling A
Allergy; 2004 Dec; 59(12):1272-6. PubMed ID: 15507095
[TBL] [Abstract][Full Text] [Related]
8. Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation.
Möbs C; Slotosch C; Löffler H; Jakob T; Hertl M; Pfützner W
J Immunol; 2010 Feb; 184(4):2194-203. PubMed ID: 20048125
[TBL] [Abstract][Full Text] [Related]
9. Cytokine and antibody responses in birch-pollen-allergic patients treated with genetically modified derivatives of the major birch pollen allergen Bet v 1.
Gafvelin G; Thunberg S; Kronqvist M; Grönlund H; Grönneberg R; Troye-Blomberg M; Akdis M; Fiebig H; Purohit A; Horak F; Reisinger J; Niederberger V; Akdis CA; Cromwell O; Pauli G; Valenta R; van Hage M
Int Arch Allergy Immunol; 2005 Sep; 138(1):59-66. PubMed ID: 16103688
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy with a modified birch pollen extract in allergic rhinoconjunctivitis: clinical and immunological effects.
Ceuppens JL; Bullens D; Kleinjans H; van der Werf J;
Clin Exp Allergy; 2009 Dec; 39(12):1903-9. PubMed ID: 20085600
[TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin G4-antibodies to rBet v 1 and risk of sensitization and atopic disease in the child.
Kihlström A; Hedlin G; Pershagen G; Troye-Blomberg M; Härfast B; Lilja G
Clin Exp Allergy; 2005 Dec; 35(12):1542-9. PubMed ID: 16393319
[TBL] [Abstract][Full Text] [Related]
12. Immunoblotting in the diagnosis of cross-reactivity in children allergic to birch.
Cudowska B; Kaczmarski M; Restani P
Rocz Akad Med Bialymst; 2005; 50():268-73. PubMed ID: 16358981
[TBL] [Abstract][Full Text] [Related]
13. Birch pollen-related food allergy: clinical aspects and the role of allergen-specific IgE and IgG4 antibodies.
Geroldinger-Simic M; Zelniker T; Aberer W; Ebner C; Egger C; Greiderer A; Prem N; Lidholm J; Ballmer-Weber BK; Vieths S; Bohle B
J Allergy Clin Immunol; 2011 Mar; 127(3):616-22.e1. PubMed ID: 21251701
[TBL] [Abstract][Full Text] [Related]
14. The allergen profile of beech and oak pollen.
Egger C; Focke M; Bircher AJ; Scherer K; Mothes-Luksch N; Horak F; Valenta R
Clin Exp Allergy; 2008 Oct; 38(10):1688-96. PubMed ID: 18754759
[TBL] [Abstract][Full Text] [Related]
15. IgG antibodies in food allergy influence allergen-antibody complex formation and binding to B cells: a role for complement receptors.
Meulenbroek LA; de Jong RJ; den Hartog Jager CF; Monsuur HN; Wouters D; Nauta AJ; Knippels LM; van Neerven RJ; Ruiter B; Leusen JH; Hack CE; Bruijnzeel-Koomen CA; Knulst AC; Garssen J; van Hoffen E
J Immunol; 2013 Oct; 191(7):3526-33. PubMed ID: 23997216
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy.
Rossi RE; Monasterolo G; Coco G; Silvestro L; Operti D
Vaccine; 2007 Jan; 25(5):957-64. PubMed ID: 17045368
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the antibody responses induced by subcutaneous injection immunotherapy with birch and Fagales pollen extracts adsorbed onto aluminum hydroxide.
Gadermaier E; Flicker S; Aberer W; Egger C; Reider N; Focke M; Vrtala S; Kundi M; Valenta R
Int Arch Allergy Immunol; 2010; 151(1):17-27. PubMed ID: 19672093
[TBL] [Abstract][Full Text] [Related]
18. Human IgG monoclonal antibodies that modulate the binding of specific IgE to birch pollen Bet v 1.
Visco V; Dolecek C; Denépoux S; Le Mao J; Guret C; Rousset F; Guinnepain MT; Kraft D; Valenta R; Weyer A; Banchereau J; Labecque S
J Immunol; 1996 Jul; 157(2):956-62. PubMed ID: 8752951
[TBL] [Abstract][Full Text] [Related]
19. Dissociation of allergen-specific IgE and IgA responses in sera and tears of pollen-allergic patients: a study performed with purified recombinant pollen allergens.
Aghayan-Ugurluoglu R; Ball T; Vrtala S; Schweiger C; Kraft D; Valenta R
J Allergy Clin Immunol; 2000 Apr; 105(4):803-13. PubMed ID: 10756233
[TBL] [Abstract][Full Text] [Related]
20. Vaccination for birch pollen allergy. Induction of affinity-matured or blocking IgG antibodies does not account for the reduced binding of IgE to Bet v 1.
Svenson M; Jacobi HH; Bødtger U; Poulsen LK; Rieneck K; Bendtzen K
Mol Immunol; 2003 Jan; 39(10):603-12. PubMed ID: 12431394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
